The company says it also will make crypto trading available in other markets later this year, though it didn't specify where.

Since early May, insider buying activity has surged at three major companies. Together, top executives and influential insiders have invested more than $170 million of their own money, sending a strong signal of confidence in the future of these stocks.

Sarepta Therapeutics Inc (NASDAQ:SRPT) shares jumped on a sweeping restructuring plan that includes cutting about 500 jobs, or 36% of its workforce, in a move aimed at reducing annual operating expenses by $400 million by 2026. The biotech company said it will sharpen its focus on high-impact drug development programs, particularly its small interfering RNA (siRNA) platform targeting neurodegenerative and pulmonary diseases such as facioscapulohumeral muscular dystrophy (FSHD), myotonic dystrophy type 1, and Huntington's disease.

Bristol Myers Squibb and Pfizer said they will start selling their blockbuster blood thinner, Eliquis, directly to some patients at a more than 40% discount. The companies' new effort would bypass traditional middlemen, including pharmacy benefit managers and insurers, to cut the drug's monthly cost from a list price of around $606 to $346.

Key Points These dividend stocks yield 5% or more.

GE beat Q2 estimates with 38% EPS growth and 23% adjusted revenue gain, driven by strength in commercial engines and services.

PepsiCo, Inc. (NASDAQ:PEP ) Q2 2025 Earnings Conference Call July 17, 2025 8:15 AM ET Company Participants James T. Caulfield - Executive VP & CFO Ramon Luis Laguarta - Chairman & CEO Ravi Pamnani - Senior Vice President of Investor Relations Conference Call Participants Andrea Faria Teixeira - JPMorgan Chase & Co, Research Division Bonnie Lee Herzog - Goldman Sachs Group, Inc., Research Division Christopher Michael Carey - Wells Fargo Securities, LLC, Research Division Dara Warren Mohsenian - Morgan Stanley, Research Division Filippo Falorni - Citigroup Inc., Research Division Kaumil S.

Novartis AG delivered strong Q2 2025 results, outpacing expectations, but faces looming patent expiries for major drugs like Entresto, Tasigna, and Promacta. Growth in new and existing pipeline drugs, plus robust financials and buybacks, position Novartis for resilience despite upcoming revenue headwinds. While the company's long-term outlook remains positive, current valuation already reflects its strengths, making shares fairly valued at this time.

Amphenol hovers near its 52-week peak as end-market expansion and targeted acquisitions drive growth momentum.

POWL's planned Remsdaq acquisition aims to boost automation offerings and expand its footprint in the utility market.

The Census Bureau's Advance Retail Sales Report for June showed consumer spending was higher than expected last month, with headline sales rising 0.6%. This marks the first monthly increase since March and was better than the expected 0.1% rise.

SHENZHEN, China , July 17, 2025 /PRNewswire/ -- MicroCloud Hologram Inc. (NASDAQ: HOLO), ("HOLO" or the "Company"), a technology service provider, announced that they have purchased up to $200 million in Bitcoin and cryptocurrency-related securities derivatives. As of July 17 , the cumulative investment income has reached $34.67million.

NEW YORK, July 17, 2025 (GLOBE NEWSWIRE) -- Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm in the 2024 ISS Securities Class Action Services Report. The firm is headquartered at the Empire State Building in New York City and is investigating Waters Corporation (NYSE: WAT ) related to its merger with BD and Company's Biosciences and Diagnostic Solutions. Upon completion of the proposed transaction, existing Waters shareholders are expected to own approximately 60.8% of the combined company. Is …

TEMPLE, Texas--(BUSINESS WIRE)--Fuzzy's Taco Shop, the fast-casual+ restaurant brand known for serving up good vibes, is making its much anticipated return to Temple, TX with a grand reopening celebration on Monday, July 21, 2025. After a devastating tornado hit the Temple community last year, this Fuzzy's restaurant has been perfecting its comeback recipe and is ready to open doors to guests once again. Located at 7425 West Adams Avenue, Suite 110, the reimagined space brings back craveable fl.

Deciding which of Lloyds Banking Group PLC (LSE:LLOY) and NatWest Group PLC (LSE:NWG) is the more profitable bank is "the ultimate question" for City philosophers, said analysts at Keefe, Bruyette and Woods. In a substantial document devoted to answering this question -- acknowledging that greater philosophers and scientists have pondered the ultimate question of life, from Socrates's examination of wisdom and virtue, to Einstein's betterment of humanity and Deep Thought mulling of the ultimate question of life, the universe and everything -- the US broker ended up upgrading its target prices for both lenders.

The case followed revelations that data from millions of Facebook users was accessed by Cambridge Analytica, a now-defunct political consulting firm that worked for Donald Trump's successful presidential campaign in 2016.

In my followup on Takeda Pharmaceutical Co (TAK), I am reaffirming my buy rating from March. Clinical demand in multiple areas, along with an active drug pipeline, could keep driving the top-line despite other big pharma names in this sector. The firm has an attractive balance sheet risk profile, along with proven growth in operating cashflow, but lacks a steady dividend growth long-term or impressive profit margins.

CRWV has had an exciting H1'25 performance, thanks to the recent IPO, the growing demand for its neocloud offerings, and the consequently rich multi-year backlog. The same has been observed in the management's laser focus on delivering growth, through hefty FY2025 capex plans, M&A activities and new investments. Even so, given the likely to be dilutive acquisition and the expensive borrowing costs on its aggressive capex, we may see CRWV report a lumpy bottom-line performance ahead.

At 221K, Initial Jobless Claims are down for the fifth week in a row from near-term highs.

US President Donald Trump has claimed that The Coca-Cola Company (NYSE:KO) will use cane sugar instead of high-fructose corn syrup for its soft drinks produced in the US. In a post on his social media platform Truth Social, Trump wrote: “This will be a very good move by them — You'll see.